Pilgrim Partners Asia Pte LTD Genmab A/S Transaction History
Pilgrim Partners Asia Pte LTD
- $115 Billion
- Q4 2024
A detailed history of Pilgrim Partners Asia Pte LTD transactions in Genmab A/S stock. As of the latest transaction made, Pilgrim Partners Asia Pte LTD holds 18,800 shares of GMAB stock, worth $370,172. This represents 0.34% of its overall portfolio holdings.
Number of Shares
18,800Holding current value
$370,172% of portfolio
0.34%Shares
1 transactions
Others Institutions Holding GMAB
# of Institutions
230Shares Held
52.1MCall Options Held
10.2KPut Options Held
25.5K-
Alliancebernstein L.P. New York, NY14.9MShares$294 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$100 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA4.42MShares$87.1 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.07MShares$60.4 Million0.44% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.93MShares$37.9 Million0.06% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $13B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...